Philippe Motté
Founder chez Celestial Consulting & Coaching
Profil
Philippe Motté is the founder of Celestial Consulting & Coaching, which was founded in 2018.
He currently holds the title of President at Celestial Consulting & Coaching.
Mr. Motté is also currently a Member at Académie nationale de Pharmacie.
In his former positions, Mr. Motté served as the Chief Regulatory & Quality Officer at Genfit SA from 2021 to 2022, and as the Chief Access Officer at MedDay Pharmaceuticals SAS from 2019 to 2020.
He also held the position of Senior Vice President-Regulatory & Quality at Gensight Biologics SA. Mr. Motté obtained an MBA from ESCP Europe Campus London and holds doctorate degrees from Universite Paris Cite and Université Paris-Saclay.
Postes actifs de Philippe Motté
| Sociétés | Poste | Début |
|---|---|---|
| Celestial Consulting & Coaching | Founder | 01/06/2018 |
| Académie nationale de Pharmacie | Corporate Officer/Principal | - |
Anciens postes connus de Philippe Motté
| Sociétés | Poste | Fin |
|---|---|---|
| GENFIT | General Counsel | 01/08/2022 |
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Corporate Officer/Principal | 01/06/2020 |
| GENSIGHT BIOLOGICS S.A. | General Counsel | - |
Formation de Philippe Motté
| ESCP Europe Campus London | Masters Business Admin |
| Universite Paris Cite | Doctorate Degree |
| Université Paris-Saclay | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GENFIT | Health Technology |
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| Entreprise privées | 3 |
|---|---|
MedDay Pharmaceuticals SAS
MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Health Technology |
| Académie nationale de Pharmacie | |
| Celestial Consulting & Coaching |
